These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15046598)

  • 1. Towards an understanding of isoform specificity in phosphoinositide 3-kinase signalling in lymphocytes.
    Fruman DA
    Biochem Soc Trans; 2004 Apr; 32(Pt 2):315-9. PubMed ID: 15046598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PI3K in lymphocyte development, differentiation and activation.
    Okkenhaug K; Vanhaesebroeck B
    Nat Rev Immunol; 2003 Apr; 3(4):317-30. PubMed ID: 12669022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances.
    So L; Fruman DA
    Biochem J; 2012 Mar; 442(3):465-81. PubMed ID: 22364281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PI3K-signalling in B- and T-cells: insights from gene-targeted mice.
    Okkenhaug K; Vanhaesebroeck B
    Biochem Soc Trans; 2003 Feb; 31(Pt 1):270-4. PubMed ID: 12546700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
    Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM
    Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells.
    Lee J; Robinson ME; Ma N; Artadji D; Ahmed MA; Xiao G; Sadras T; Deb G; Winchester J; Cosgun KN; Geng H; Chan LN; Kume K; Miettinen TP; Zhang Y; Nix MA; Klemm L; Chen CW; Chen J; Khairnar V; Wiita AP; Thomas-Tikhonenko A; Farzan M; Jung JU; Weinstock DM; Manalis SR; Diamond MS; Vaidehi N; Müschen M
    Nature; 2020 Dec; 588(7838):491-497. PubMed ID: 33149299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of phosphoinositide 3-kinase signaling in autoimmunity.
    Oak JS; Fruman DA
    Autoimmunity; 2007 Sep; 40(6):433-41. PubMed ID: 17729037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoinositide 3-kinase in T cell activation and survival.
    Okkenhaug K; Bilancio A; Emery JL; Vanhaesebroeck B
    Biochem Soc Trans; 2004 Apr; 32(Pt 2):332-5. PubMed ID: 15046602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring phosphorylated Akt and other phosphoinositide 3-kinase-regulated phosphoproteins in primary lymphocytes.
    Donahue AC; Kharas MG; Fruman DA
    Methods Enzymol; 2007; 434():131-54. PubMed ID: 17954246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells.
    Barata JT; Silva A; Brandao JG; Nadler LM; Cardoso AA; Boussiotis VA
    J Exp Med; 2004 Sep; 200(5):659-69. PubMed ID: 15353558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphoinositide 3-kinase: diverse roles in immune cell activation.
    Deane JA; Fruman DA
    Annu Rev Immunol; 2004; 22():563-98. PubMed ID: 15032589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PI3K signaling controls cell fate at many points in B lymphocyte development and activation.
    Donahue AC; Fruman DA
    Semin Cell Dev Biol; 2004 Apr; 15(2):183-97. PubMed ID: 15209378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of class I phosphoinositide 3-kinase in T-cell function and autoimmunity.
    Fruman DA
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):177-80. PubMed ID: 17371231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphoinositide 3-kinase signalling regulates early development and developmental haemopoiesis.
    Bone HK; Welham MJ
    J Cell Sci; 2007 May; 120(Pt 10):1752-62. PubMed ID: 17456549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
    Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
    J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of phosphoinositide 3OH-kinase in autocrine transformation by PDGF-BB.
    Rosenmüller T; Rydh K; Nånberg E
    J Cell Physiol; 2001 Sep; 188(3):369-82. PubMed ID: 11473364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD19 differentially regulates BCR signalling through the recruitment of PI3K.
    Xu Y; Fairfax K; Light A; Huntington ND; Tarlinton DM
    Autoimmunity; 2014 Nov; 47(7):430-7. PubMed ID: 24953501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of class IA phosphoinositide 3-kinase in B lymphocyte development and functions.
    Koyasu S
    Biochem Soc Trans; 2004 Apr; 32(Pt 2):320-5. PubMed ID: 15046599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The catalytic PI3K isoforms p110gamma and p110delta contribute to B cell development and maintenance, transformation, and proliferation.
    Beer-Hammer S; Zebedin E; von Holleben M; Alferink J; Reis B; Dresing P; Degrandi D; Scheu S; Hirsch E; Sexl V; Pfeffer K; Nürnberg B; Piekorz RP
    J Leukoc Biol; 2010 Jun; 87(6):1083-95. PubMed ID: 20200404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoinositide-3 kinase-PKB/Akt pathway activation is involved in fibroblast Rat-1 transformation by human T-cell leukemia virus type I tax.
    Liu Y; Wang Y; Yamakuchi M; Masuda S; Tokioka T; Yamaoka S; Maruyama I; Kitajima I
    Oncogene; 2001 May; 20(20):2514-26. PubMed ID: 11420661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.